The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Goldman Sachs Future Health Care Eq ETF GDOC
Morningstar’s Analysis GDOC
Will GDOC outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 50.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 10.18 | 2.5 Mil | Healthcare |
Novo Nordisk A/S Class B | 6.18 | 1.5 Mil | Healthcare |
AstraZeneca PLC | 5.90 | 1.5 Mil | Healthcare |
Boston Scientific Corp | 5.76 | 1.4 Mil | Healthcare |
Intuitive Surgical Inc | 4.53 | 1.1 Mil | Healthcare |
Danaher Corp | 3.74 | 936,001 | Healthcare |
Amgen Inc | 3.59 | 899,400 | Healthcare |
Biomarin Pharmaceutical Inc | 3.41 | 854,685 | Healthcare |
The Cooper Companies Inc | 3.40 | 850,240 | Healthcare |
Zimmer Biomet Holdings Inc | 3.39 | 850,032 | Healthcare |